Mark Levine

Levine is an active clinical trials investigator in the areas of breast cancer, venous thromboembolism, and has performed research in quality of life and decision-making in breast cancer.

The Clinical Trials Methodology Group which he leads is conducting trials in a number of areas including: radiation therapy in breast and prostate cancers, vaccine therapy in breast cancer, and evaluation of PET imaging in oncology.